L. Faerber

601 total citations
21 papers, 476 citations indexed

About

L. Faerber is a scholar working on Molecular Biology, Surgery and Physiology. According to data from OpenAlex, L. Faerber has authored 21 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Surgery and 4 papers in Physiology. Recurrent topics in L. Faerber's work include Nausea and vomiting management (6 papers), Renal Transplantation Outcomes and Treatments (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). L. Faerber is often cited by papers focused on Nausea and vomiting management (6 papers), Renal Transplantation Outcomes and Treatments (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). L. Faerber collaborates with scholars based in Germany, United States and Austria. L. Faerber's co-authors include S. Drechsler, Harald Gschaidmeier, S. Ladenburger, Wolfgang B. Fischer, Frieder Kees, Michael Bucher, Frank Schweda, H Meffert, G. Mahrle and Matthias Braeutigam and has published in prestigious journals such as PLoS ONE, European Journal of Pharmacology and European Journal of Cancer.

In The Last Decade

L. Faerber

21 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Faerber Germany 10 98 92 74 66 59 21 476
Eckhard Schwertfeger Germany 13 152 1.6× 114 1.2× 34 0.5× 68 1.0× 66 1.1× 19 548
L. Färber Germany 19 111 1.1× 182 2.0× 106 1.4× 55 0.8× 48 0.8× 44 889
Vince Fazio United States 8 211 2.2× 72 0.8× 42 0.6× 15 0.2× 28 0.5× 9 552
Sandra van den Engel Netherlands 13 220 2.2× 245 2.7× 246 3.3× 51 0.8× 38 0.6× 19 809
Fu Liang Ng United Kingdom 14 295 3.0× 77 0.8× 47 0.6× 40 0.6× 48 0.8× 25 693
Madeleine Vincent France 18 226 2.3× 110 1.2× 211 2.9× 51 0.8× 45 0.8× 39 971
Annemarie Goldbecker Germany 17 89 0.9× 123 1.3× 90 1.2× 11 0.2× 22 0.4× 28 844
Lingzhi Li China 18 271 2.8× 89 1.0× 62 0.8× 18 0.3× 23 0.4× 55 829
Ken Ohtsuka Japan 11 125 1.3× 169 1.8× 54 0.7× 95 1.4× 28 0.5× 15 482
Yat-Ching Tong Taiwan 14 93 0.9× 133 1.4× 56 0.8× 7 0.1× 39 0.7× 36 596

Countries citing papers authored by L. Faerber

Since Specialization
Citations

This map shows the geographic impact of L. Faerber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Faerber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Faerber more than expected).

Fields of papers citing papers by L. Faerber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Faerber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Faerber. The network helps show where L. Faerber may publish in the future.

Co-authorship network of co-authors of L. Faerber

This figure shows the co-authorship network connecting the top 25 collaborators of L. Faerber. A scholar is included among the top collaborators of L. Faerber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Faerber. L. Faerber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walz, Johanna M., Thomas Wecker, Bertan Cakir, et al.. (2019). Impact of angiogenic activation and inhibition on miRNA profiles of human retinal endothelial cells. Experimental Eye Research. 181. 98–104. 20 indexed citations
2.
3.
Kees, Frieder, et al.. (2017). Differences in the renal antifibrotic cGMP/cGKI-dependent signaling of serelaxin, zaprinast, and their combination. Naunyn-Schmiedeberg s Archives of Pharmacology. 390(9). 939–948. 5 indexed citations
4.
Kees, Frieder, et al.. (2016). Involvement of Cyclic Guanosine Monophosphate-Dependent Protein Kinase I in Renal Antifibrotic Effects of Serelaxin. Frontiers in Pharmacology. 7. 195–195. 13 indexed citations
5.
Walz, Johanna M., Daniel Boehringer, Heidrun L. Deissler, et al.. (2016). Pre-Analytical Parameters Affecting Vascular Endothelial Growth Factor Measurement in Plasma: Identifying Confounders. PLoS ONE. 11(1). e0145375–e0145375. 20 indexed citations
6.
Zschiedrich, Stefan, Klemens Budde, Jens Nürnberger, et al.. (2015). Secreted frizzled-related protein 4 predicts progression of autosomal dominant polycystic kidney disease. Nephrology Dialysis Transplantation. 31(2). 284–289. 8 indexed citations
7.
Schlossmann, Jens, et al.. (2015). Antifibrotic function of cGKI in the kidney. BMC Pharmacology and Toxicology. 16(S1). 1 indexed citations
8.
Kees, Martin G., Thomas Steinke, Stefan Moritz, et al.. (2011). Omeprazole Impairs the Absorption of Mycophenolate Mofetil But Not of Enteric‐Coated Mycophenolate Sodium in Healthy Volunteers. The Journal of Clinical Pharmacology. 52(8). 1265–1272. 39 indexed citations
9.
Schmidt, Christoph, Frank Schweda, Maria Shipkova, et al.. (2009). Bioavailability of Mycophenolate Mofetil and Enteric‐Coated Mycophenolate Sodium Is Differentially Affected by Pantoprazole in Healthy Volunteers. The Journal of Clinical Pharmacology. 49(10). 1196–1201. 47 indexed citations
10.
Faerber, L., S. Drechsler, S. Ladenburger, Harald Gschaidmeier, & Wolfgang B. Fischer. (2007). The neuronal 5-HT3 receptor network after 20 years of research — Evolving concepts in management of pain and inflammation. European Journal of Pharmacology. 560(1). 1–8. 177 indexed citations
11.
Kees, Frieder, Michael Bucher, Frank Schweda, et al.. (2007). Neoimmun versus Neoral: a bioequivalence study in healthy volunteers and influence of a fat-rich meal on the bioavailability of Neoimmun. Naunyn-Schmiedeberg s Archives of Pharmacology. 375(6). 393–399. 16 indexed citations
12.
Kees, Frieder, Michael Bucher, Frank Schweda, et al.. (2006). Comparative Bioavailability of the Microemulsion Formulation of Cyclosporine (Neoral) With a Generic Dispersion Formulation (Cicloral) in Young Healthy Male Volunteers. Therapeutic Drug Monitoring. 28(3). 312–320. 8 indexed citations
13.
Ittner, Karl Peter, Michael Pawlik, Martina E. Zimmermann, K. Taeger, & L. Faerber. (2006). Urapidil enhances subcutaneous tissue oxygen tension during convective rewarming of mildly hypothermic rats. Journal of Thermal Biology. 31(1-2). 144–148. 1 indexed citations
14.
Ittner, Karl Peter, et al.. (2004). Effect of tropisetron versus placebo on cold-induced oxygen consumption and shivering in male volunteers. Journal of Thermal Biology. 29(7-8). 845–849. 1 indexed citations
15.
Faerber, L., Matthias Braeutigam, Gottfried Weidinger, et al.. (2001). Cyclosporine in Severe Psoriasis. American Journal of Clinical Dermatology. 2(1). 41–47. 61 indexed citations
16.
Drechsler, S., U. Bruntsch, Markus Bangerter, et al.. (1997). Comparison of three tropisetron-containing antiemetic regimens in the prophylaxis of acute and delayed chemotherapy-induced emesis and nausea. Supportive Care in Cancer. 5(5). 387–395. 13 indexed citations
17.
Gaedicke, Gerhard, R. Erttmann, Wolfgang Hartmann, et al.. (1996). Pharmacokinetics of the 5HT3Receptor Antagonist Tropisetron in Children. Pediatric Hematology and Oncology. 13(5). 405–416. 6 indexed citations
18.
Garbe, Claus, S. Drechsler, Wolfgang Tilgen, et al.. (1994). Dose comparison of tropisetron (Navoban) 5 mg and 10 mg orally in the prophylaxis of dacarbazine-induced nausea and emesis.. PubMed. 21(5 Suppl 9). 12–6. 8 indexed citations
19.
Rieß, H., et al.. (1993). Tropisetron (TRO) VS. ondansetron (OND) in prophylaxis of chemotherapy-induced emesis (CIE). European Journal of Cancer. 29. S211–S211. 1 indexed citations
20.
Bruntsch, U., et al.. (1993). Optimal treatment with tropisetron (TRO) in acute and delayed chemotherapy-induced emesis (CIE). European Journal of Cancer. 29. S211–S211. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eckhard Schwertfeger Breakdown of academic impact, for papers by L. Färber Breakdown of academic impact, for papers by Vince Fazio Breakdown of academic impact, for papers by Sandra van den Engel Breakdown of academic impact, for papers by Fu Liang Ng Breakdown of academic impact, for papers by Madeleine Vincent Breakdown of academic impact, for papers by Annemarie Goldbecker Breakdown of academic impact, for papers by Lingzhi Li Breakdown of academic impact, for papers by Ken Ohtsuka Breakdown of academic impact, for papers by Yat-Ching Tong
Rankless by CCL
2026